// App-Quantinova.ai

BSH2020‐EP‐101 : Real‐world experience of KPD use in relapsed or refractory myeloma

Researchers

Presenter

  • A. Barrett

Principal Investigators

  • F. Gul

  • A. Nee

  • H. O'Leary

  • D. O'Keefe

Medical Centers

  • University Hospital Limerick, Limerick, Ireland, Limerick, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Musculoskeletal

Disease

  • Deep vein thrombosis

  • Avascular necrosis

  • Venous thrombosis

  • Multiple Myeloma

  • Congestive heart failure

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • carfilzomib Intravenous

  • Thalidomide

  • Bortezomib

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved